PetMed Express Inc. (NASDAQ:PETS) will be announcing its earnings results before the market opens on Thursday, November 24th.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings data on Monday, October 24th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.26 by $0.02. The firm had revenue of $60.80 million for the quarter, compared to analyst estimates of $58.47 million. PetMed Express had a net margin of 9.10% and a return on equity of 25.77%. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.22 EPS. On average, analysts expect PetMed Express to post $1.09 EPS for the current fiscal year and $1.15 EPS for the next fiscal year.

Earnings History for PetMed Express (NASDAQ:PETS)

PetMed Express Inc. (NASDAQ:PETS) opened at 21.88 on Wednesday. The firm has a market cap of $443.14 million, a PE ratio of 20.45 and a beta of 1.11. The stock has a 50 day moving average of $20.52 and a 200 day moving average of $19.85. PetMed Express Inc. has a 12-month low of $15.73 and a 12-month high of $22.25.

The business also recently announced a quarterly dividend, which was paid on Friday, November 18th. Stockholders of record on Monday, November 7th were issued a $0.19 dividend. The ex-dividend date of this dividend was Thursday, November 3rd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 3.47%. PetMed Express’s dividend payout ratio (DPR) is currently 71.03%.

A number of research firms have recently commented on PETS. Zacks Investment Research raised shares of PetMed Express from a “sell” rating to a “hold” rating in a report on Monday. Credit Suisse Group AG reissued a “sell” rating and issued a $13.00 target price on shares of PetMed Express in a report on Tuesday, August 16th.

In related news, insider Bruce S. Rosenbloom sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, November 14th. The shares were sold at an average price of $21.75, for a total value of $65,250.00. Following the completion of the transaction, the insider now owns 38,767 shares in the company, valued at approximately $843,182.25. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Menderes Akdag sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, October 10th. The shares were sold at an average price of $21.00, for a total transaction of $210,000.00. Following the completion of the transaction, the chief executive officer now owns 600,000 shares of the company’s stock, valued at approximately $12,600,000. The disclosure for this sale can be found here. 4.70% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of PETS. American International Group Inc. raised its position in shares of PetMed Express by 0.3% in the third quarter. American International Group Inc. now owns 14,859 shares of the company’s stock worth $301,000 after buying an additional 46 shares during the period. Arizona State Retirement System raised its position in shares of PetMed Express by 1.9% in the second quarter. Arizona State Retirement System now owns 10,467 shares of the company’s stock worth $196,000 after buying an additional 200 shares during the period. Rhumbline Advisers raised its position in shares of PetMed Express by 0.4% in the second quarter. Rhumbline Advisers now owns 57,444 shares of the company’s stock worth $1,078,000 after buying an additional 247 shares during the period. Paradigm Asset Management Co. LLC raised its position in shares of PetMed Express by 2.3% in the second quarter. Paradigm Asset Management Co. LLC now owns 17,500 shares of the company’s stock worth $328,000 after buying an additional 400 shares during the period. Finally, California State Teachers Retirement System raised its position in shares of PetMed Express by 1.0% in the third quarter. California State Teachers Retirement System now owns 41,969 shares of the company’s stock worth $851,000 after buying an additional 400 shares during the period. Institutional investors and hedge funds own 75.57% of the company’s stock.

TRADEMARK VIOLATION WARNING: “PetMed Express Inc. (PETS) Scheduled to Post Quarterly Earnings on Thursday” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/23/petmed-express-inc-pets-scheduled-to-post-quarterly-earnings-on-thursday.html.

PetMed Express Company Profile

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

5 Day Chart for NASDAQ:PETS

Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.